Oceania Healthcare(NZ:OCA)
NZ$0.59-0.03 (-4.84%)
NZ:OCA
Oceania Healthcare financials statements
NZ$0.59
At close:-0.03 (-4.84%)
Want to see NZ:OCA full AI Analyst Report?
Oceania Healthcare (OCA) Ratios
1 Followers
Oceania Healthcare Ratios
NZ:OCA's free cash flow for Q2 2027 was NZ$39.17M. For the 2027 fiscal year, NZ:OCA's free cash flow was decreased by NZ$-8.32M and operating cash flow was NZ$47.49M. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.12 | 0.11 | 0.16 | 0.22 | 0.10 |
| Quick Ratio | 0.12 | 0.11 | 0.16 | 0.22 | 0.10 |
| Cash Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Solvency Ratio | 0.01 | 0.03 | 0.03 | 0.02 | 0.06 |
| Operating Cash Flow Ratio | 0.12 | 0.09 | 0.08 | 0.02 | 0.02 |
| Short-Term Operating Cash Flow Coverage | 88.90 | 0.00 | 0.00 | 0.00 | 5.73 |
| Net Current Asset Value | NZ$ -1.74B | NZ$ -1.71B | NZ$ -1.58B | NZ$ -1.36B | NZ$ -1.17B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.17 | 0.22 | 0.23 | 0.22 | 0.18 |
| Debt-to-Equity Ratio | 0.45 | 0.58 | 0.63 | 0.58 | 0.42 |
| Debt-to-Capital Ratio | 0.31 | 0.37 | 0.39 | 0.37 | 0.29 |
| Long-Term Debt-to-Capital Ratio | 0.30 | 0.36 | 0.38 | 0.37 | 0.29 |
| Financial Leverage Ratio | 2.61 | 2.67 | 2.71 | 2.64 | 2.32 |
| Debt Service Coverage Ratio | 0.45 | 3.49 | 4.16 | 3.56 | 7.32 |
| Interest Coverage Ratio | -0.81 | -1.00 | 5.00 | 6.23 | 8.16 |
| Debt to Market Cap | 1.02 | 1.42 | 1.41 | 1.06 | 0.53 |
| Interest Debt Per Share | 0.76 | 0.91 | 0.92 | 0.80 | 0.57 |
| Net Debt to EBITDA | 127.68 | 9.27 | 10.17 | 12.58 | 4.62 |
| Profitability Margins | |||||
| Gross Profit Margin | 16.85% | 100.00% | 100.00% | 33.46% | 32.32% |
| EBIT Margin | -7.39% | 17.62% | 16.71% | 10.47% | 28.16% |
| EBITDA Margin | 1.50% | 26.12% | 23.87% | 17.72% | 36.22% |
| Operating Profit Margin | -7.39% | -8.03% | 30.10% | 33.39% | 31.24% |
| Pretax Profit Margin | -2.89% | 9.92% | 10.70% | 4.85% | 24.34% |
| Net Profit Margin | 0.04% | 11.67% | 11.86% | 6.25% | 26.45% |
| Continuous Operations Profit Margin | 0.04% | 11.67% | 11.86% | 6.25% | 26.45% |
| Net Income Per EBT | -1.54% | 117.64% | 110.85% | 128.73% | 108.67% |
| EBT Per EBIT | 39.04% | -123.50% | 35.53% | 14.54% | 77.91% |
| Return on Assets (ROA) | 0.00% | 1.03% | 1.13% | 0.61% | 2.78% |
| Return on Equity (ROE) | 0.01% | 2.76% | 3.07% | 1.61% | 6.44% |
| Return on Capital Employed (ROCE) | -1.12% | -1.20% | 4.76% | 5.43% | 5.39% |
| Return on Invested Capital (ROIC) | 0.02% | -1.20% | 4.76% | 5.42% | 5.37% |
| Return on Tangible Assets | 0.00% | 1.04% | 1.13% | 0.61% | 2.79% |
| Earnings Yield | 0.02% | 6.88% | 6.95% | 2.95% | 8.41% |
| Efficiency Ratios | |||||
| Receivables Turnover | 1.95 | 2.30 | 2.31 | 2.32 | 3.48 |
| Payables Turnover | 11.21 | 57.12 | 12.39 | 16.81 | 76.58 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.30 | 0.31 | 0.34 | 0.35 | 0.32 |
| Asset Turnover | 0.09 | 0.09 | 0.10 | 0.10 | 0.11 |
| Working Capital Turnover Ratio | -0.24 | -0.26 | -0.31 | -0.31 | -0.36 |
| Cash Conversion Cycle | 154.28 | 152.02 | 128.83 | 135.50 | 100.16 |
| Days of Sales Outstanding | 186.84 | 158.41 | 158.29 | 157.22 | 104.93 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 32.56 | 6.39 | 29.46 | 21.72 | 4.77 |
| Operating Cycle | 186.84 | 158.41 | 158.29 | 157.22 | 104.93 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.22 | 0.15 | 0.12 | 0.02 | 0.03 |
| Free Cash Flow Per Share | 0.19 | 0.10 | 0.05 | -0.06 | -0.05 |
| Dividend Paid and CapEx Coverage Ratio | 8.87 | 2.77 | 1.45 | 0.20 | 0.25 |
| Capital Expenditure Coverage Ratio | 8.87 | 2.77 | 1.64 | 0.28 | 0.33 |
| Operating Cash Flow Coverage Ratio | 0.30 | 0.17 | 0.13 | 0.03 | 0.05 |
| Operating Cash Flow to Sales Ratio | 0.59 | 0.42 | 0.32 | 0.06 | 0.08 |
| Free Cash Flow Yield | 27.62% | 15.95% | 7.36% | -7.59% | -5.18% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 3500.00 | 14.52 | 14.39 | 33.88 | 11.89 |
| Price-to-Sales (P/S) Ratio | 1.90 | 1.70 | 1.71 | 2.12 | 3.14 |
| Price-to-Book (P/B) Ratio | 0.43 | 0.40 | 0.44 | 0.54 | 0.77 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 3.62 | 6.27 | 13.58 | -13.18 | -19.30 |
| Price-to-Operating Cash Flow Ratio | 3.21 | 4.01 | 5.31 | 33.88 | 39.04 |
| Price-to-Earnings Growth (PEG) Ratio | -35.17 | -4.21 | 0.14 | -0.45 | -0.24 |
| Enterprise Value Multiple | 254.55 | 15.76 | 17.32 | 24.53 | 13.30 |
| Enterprise Value | 1.02B | 1.07B | 1.10B | 1.07B | 1.11B |
| EV to EBITDA | 254.55 | 15.76 | 17.32 | 24.53 | 13.30 |
| EV to Sales | 3.81 | 4.12 | 4.13 | 4.35 | 4.82 |
| EV to Free Cash Flow | 7.27 | 15.22 | 32.89 | -27.05 | -29.56 |
| EV to Operating Cash Flow | 6.45 | 9.73 | 12.85 | 69.55 | 59.80 |
| Tangible Book Value Per Share | 1.62 | 1.51 | 1.41 | 1.34 | 1.33 |
| Shareholders’ Equity Per Share | 1.63 | 1.52 | 1.42 | 1.35 | 1.35 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 1.02 | -0.18 | -0.11 | -0.29 | -0.09 |
| Revenue Per Share | 0.37 | 0.36 | 0.37 | 0.35 | 0.33 |
| Net Income Per Share | 0.00 | 0.04 | 0.04 | 0.02 | 0.09 |
| Tax Burden | -0.02 | 1.18 | 1.11 | 1.29 | 1.09 |
| Interest Burden | 0.39 | 0.56 | 0.64 | 0.46 | 0.86 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.23 | 0.68 | 0.67 | 0.67 | 0.69 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1326.02 | 3.63 | 2.71 | 1.00 | 0.30 |
Currency in NZD

